BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 8466274)

  • 21. Using dexamethasone to treat bronchopulmonary dysplasia.
    Van Ekeren RF
    Neonatal Netw; 1991 Oct; 10(3):17-21. PubMed ID: 1944082
    [No Abstract]   [Full Text] [Related]  

  • 22. The effect of intravenous ranitidine on the intragastric pH of preterm infants receiving dexamethasone.
    Kelly EJ; Chatfield SL; Brownlee KG; Ng PC; Newell SJ; Dear PR; Primrose JN
    Arch Dis Child; 1993 Jul; 69(1 Spec No):37-9. PubMed ID: 8346951
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dexamethasone in the treatment of bronchopulmonary dysplasia.
    Benini F; Rubaltelli FF; Griffith P; Sala M; Zorzi C
    Acta Paediatr Scand Suppl; 1989; 360():108-12. PubMed ID: 2642245
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of dexamethasone on protein metabolism in infants with bronchopulmonary dysplasia.
    Van Goudoever JB; Wattimena JD; Carnielli VP; Sulkers EJ; Degenhart HJ; Sauer PJ
    J Pediatr; 1994 Jan; 124(1):112-8. PubMed ID: 8283359
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Dexamethasone therapy in bronchopulmonary dysplasia].
    Merz U; Kuehl G; Linderkamp O
    Klin Padiatr; 1989; 201(1):11-5. PubMed ID: 2495383
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hypertrophy of the tongue associated with inhaled corticosteroid therapy in premature infants.
    Linder N; Kuint J; German B; Lubin D; Loewenthal R
    J Pediatr; 1995 Oct; 127(4):651-3. PubMed ID: 7562295
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Postnatal steroids for the treatment of bronchopulmonary dysplasia: a complex case presentation.
    Forest S
    J Perinat Neonatal Nurs; 2011; 25(3):283-91; quiz 292-3. PubMed ID: 21825919
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Delayed Dexamethasone Therapy and Neurodevelopmental Outcomes in Preterm Infants with Bronchopulmonary Dysplasia.
    Lim G; Lee BS; Choi YS; Park HW; Chung ML; Choi HJ; Kim EA; Kim KS
    Pediatr Neonatol; 2015 Aug; 56(4):261-7. PubMed ID: 25649722
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of dexamethasone on leukocyte numbers and lymphocyte-blastogenic responses to mitogens in infants with bronchopulmonary dysplasia.
    Moya FR; Becerra M; Leiva L; Sorensen RU
    Clin Pediatr (Phila); 1993 Mar; 32(3):185-8. PubMed ID: 8453841
    [No Abstract]   [Full Text] [Related]  

  • 30. Finding the optimal postnatal dexamethasone regimen for preterm infants at risk of bronchopulmonary dysplasia: a systematic review of placebo-controlled trials.
    Onland W; Offringa M; De Jaegere AP; van Kaam AH
    Pediatrics; 2009 Jan; 123(1):367-77. PubMed ID: 19117904
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Diabetic ketoacidosis after steroid administration for bronchopulmonary dysplasia: a case report.
    Spear ML; Reeves G; Pearlman SA
    J Perinatol; 1993; 13(3):232-4. PubMed ID: 8345389
    [No Abstract]   [Full Text] [Related]  

  • 32. Dexamethasone increases plasma amino acid concentrations in bronchopulmonary dysplasia.
    Williams AF; Jones M
    Arch Dis Child; 1992 Jan; 67(1 Spec No):5-9. PubMed ID: 1536587
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hydrocortisone vs. dexamethasone treatment for bronchopulmonary dysplasia and their effects on general movements in preterm infants.
    Hitzert MM; Benders MJ; Roescher AM; van Bel F; de Vries LS; Bos AF
    Pediatr Res; 2012 Jan; 71(1):100-6. PubMed ID: 22289857
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Function of the hypothalamo-hypophyseal-adrenal axis to corticotropin-releasing hormone test in premature infants with bronchopulmonary dysplasia].
    Merz U; Pfäffle R; Peschgens T; Hörnchen H
    Z Geburtshilfe Neonatol; 1997; 201(6):253-7. PubMed ID: 9491545
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Reversible obstructive hypertrophic cardiomyopathy after dexamethasone therapy for bronchopulmonary dysplasia.
    Ohning BL; Fyfe DA; Riedel PA
    Am Heart J; 1993 Jan; 125(1):253-6. PubMed ID: 8417533
    [No Abstract]   [Full Text] [Related]  

  • 36. Renal calcification after dexamethasone in infants with bronchopulmonary dysplasia.
    Kamitsuka MD; Peloquin D
    Lancet; 1991 Mar; 337(8741):626. PubMed ID: 1671989
    [No Abstract]   [Full Text] [Related]  

  • 37. [The use of corticosteroids in bronchopulmonary dysplasia].
    Wesselink MW; van den Anker JN; Sauer PJ
    Ned Tijdschr Geneeskd; 1991 May; 135(21):943-6. PubMed ID: 2052111
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lower gastrointestinal tract perforation in preterm infants treated with dexamethasone for bronchopulmonary dysplasia.
    Ng PC; Fok TF; So KW; Wong W; Yip PK; Liu K
    Pediatr Surg Int; 1997 Feb; 12(2-3):211-2. PubMed ID: 9156866
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dexamethasone effects on the hospital course of infants with bronchopulmonary dysplasia who are dependent on artificial ventilation.
    Kazzi NJ; Brans YW; Poland RL
    Pediatrics; 1990 Nov; 86(5):722-7. PubMed ID: 2235226
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Glucocorticoide therapy in premature infants: French practices in 2006].
    Autret-Leca E; Bauer S; Alberti C; Jonville-Béra AP; Aujard Y; Bensouda-Grimaldi L; Baud O
    Arch Pediatr; 2009 Jul; 16(7):999-1004. PubMed ID: 19410441
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.